Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Milwaukee Journal Sentinel Story on Use of Surrogate Measures

lab_tech

Earlier this week, John Fauber of the Milwaukee Journal Sentinel wrote an article on measures used to determine whether new medicines for serious and life-threatening diseases should reach patients. Fauber seem(s) to suggest that the use of surrogate measures – such as tumor shrinkage – do not provide evidence of drug efficacy. The story fails to present a balanced view of the complex benefit-risk assessments that the FDA must carefully consider when reviewing applications for Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

CQ HealthBeat: Ebola Crisis

scientist-eyedropper

Last week, CQ HealthBeat published a ‘Did you know?’ infographic on Washington’s reaction to the Ebola crisis. Here are a few numbers you may not know: 5: The number of U.S. airports where passengers from Liberia, Sierra Leone and Guinea are being screened for Ebola 72: The number of people being monitored for the Ebola virus in Spain, after a nurse contracted the virus 4,000: The number of U.S. military troops to be deployed to Africa Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Patient & Health Advocacy Summit: Youth Rally Transforms Patients’ Lives

BIOP&H

The recent BIO Patient & Health Advocacy Summit brought together industry and advocacy groups to share insights and perspectives on how to accelerate the development of cures and treatments and improve the lives of patients overall. Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals Inc. highlighted one such effort to help improve the lives of young people dealing with a range of bladder and bowel issues. Youth Rally Committee, Inc. provides young people with opportunities Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Patient & Health Advocacy Summit: The Power of Partnerships

patient-summit-4

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient advocacy organizations, government agencies and industry leaders to discuss how to accelerate R&D, preserve patient access, leverage data and build collaborations focused on empowering patients. The rallying cry that reverberated throughout the event and over Twitter seemed clear from the beginning and Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Inc. captured it Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Richard Pops: A Greater Patient Voice in Drug Development

ph-summit

In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward increased engagement with patients in the development, review and delivery of new medicines, as well as the challenges and opportunities associated with access and reimbursement. Pops asserts that patients must organize to share data that can be used in regulatory decision-making. Furthermore, he writes that this input must be integrated through the process – from the early stages of development Read More >

Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,